Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Xilio Therapeutics, Inc. | CHIEF FINANCIAL OFFICER | Stock Option (right to buy) | 49.5K | Feb 22, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
XLO | Xilio Therapeutics, Inc. | Feb 22, 2022 | 1 | $0 | 4 | Feb 24, 2022 | CHIEF FINANCIAL OFFICER |
XLO | Xilio Therapeutics, Inc. | Oct 21, 2021 | 1 | $0 | 4 | Oct 25, 2021 | Chief Financial Officer |
XLO | Xilio Therapeutics, Inc. | Oct 21, 2021 | 0 | $0 | 3 | Oct 21, 2021 | Chief Financial Officer |